<?xml version="1.0" encoding="UTF-8"?>
<p>Last but not the least, a number of non-specific treatments can bring about clinical improvements, such as statins, heparin, and vitamin C. In addition to the molecules described by WHO, recent studies suggest other possible treatments for SARS-CoV-2. Mesenchymal stem cells are the subject of several phase I and II studies, carried out within the SARS-CoV-2 infection. The therapeutic hypothesis is that the immunomodulatory and regenerative properties of stem cells can inhibit the inflammatory component of SARS-COV-2 lung disease (which can lead to fatal disease progression) (
 <xref rid="B84" ref-type="bibr">84</xref>).
</p>
